Haemonetics Corp. (HAE)
118.69
-0.78
(-0.65%)
USD |
NYSE |
Oct 09, 16:00
118.73
+0.04
(+0.03%)
After-Hours: 20:00
Haemonetics Cash from Operations (Quarterly) : 52.32M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 52.32M |
| March 31, 2026 | 70.94M |
| December 31, 2025 | 93.56M |
| September 30, 2025 | 111.32M |
| June 30, 2025 | 17.40M |
| March 31, 2025 | 116.56M |
| December 31, 2024 | 43.77M |
| September 30, 2024 | 48.82M |
| June 30, 2024 | -27.42M |
| March 31, 2024 | 64.08M |
| December 31, 2023 | -0.54M |
| September 30, 2023 | 99.12M |
| June 30, 2023 | 19.09M |
| March 31, 2023 | 78.49M |
| December 31, 2022 | 64.42M |
| September 30, 2022 | 87.04M |
| June 30, 2022 | 41.99M |
| March 31, 2022 | 68.05M |
| December 31, 2021 | 62.43M |
| September 30, 2021 | 43.46M |
| June 30, 2021 | -1.68M |
| March 31, 2021 | 1.547M |
| December 31, 2020 | 66.29M |
| September 30, 2020 | 29.16M |
| June 30, 2020 | 11.81M |
| Date | Value |
|---|---|
| March 31, 2020 | 46.41M |
| December 31, 2019 | 79.28M |
| September 30, 2019 | 29.90M |
| June 30, 2019 | 2.628M |
| March 31, 2019 | 20.64M |
| December 31, 2018 | 58.16M |
| September 30, 2018 | 57.36M |
| June 30, 2018 | 23.12M |
| March 31, 2018 | 57.63M |
| December 31, 2017 | 65.40M |
| September 30, 2017 | 58.90M |
| June 30, 2017 | 38.42M |
| March 31, 2017 | 34.58M |
| December 31, 2016 | 55.20M |
| September 30, 2016 | 39.26M |
| June 30, 2016 | 30.70M |
| March 31, 2016 | 53.25M |
| December 31, 2015 | 31.85M |
| September 30, 2015 | 27.51M |
| June 30, 2015 | 9.25M |
| March 31, 2015 | 55.30M |
| December 31, 2014 | 26.89M |
| September 30, 2014 | 31.24M |
| June 30, 2014 | 13.74M |
| March 31, 2014 | 51.47M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| ICU Medical, Inc. | 80.15M |
| Merit Medical Systems, Inc. | 69.28M |
| Teleflex, Inc. | 94.33M |
| Globus Medical, Inc. | 209.74M |
| Abbott Laboratories | 2.488B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -22.23M |
| Cash from Financing (Quarterly) | -51.53M |
| Free Cash Flow | 291.22M |
| Free Cash Flow Per Share (Quarterly) | 0.9718 |
| Free Cash Flow to Equity (Quarterly) | 144.98M |
| Free Cash Flow to Firm (Quarterly) | 51.47M |
| Free Cash Flow Yield | 5.26% |